The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 19, 2008

Filed:

Dec. 18, 2003
Applicants:

Bernhard M. Schilling, Syracuse, NY (US);

Scott Gangloff, Bensalem, PA (US);

Dharti Kothari, Princeton, NJ (US);

Kirk Leister, Fayetteville, NY (US);

Linda Matlock, Parish, NY (US);

Stephen G. Zegarelli, North Syracuse, NY (US);

Christoph E. Joosten, Manlius, NY (US);

Jonathan D. Basch, DeWitt, NY (US);

Sivakesava Sakhamuri, Manlius, NY (US);

Steven S. Lee, Manlius, NY (US);

Inventors:

Bernhard M. Schilling, Syracuse, NY (US);

Scott Gangloff, Bensalem, PA (US);

Dharti Kothari, Princeton, NJ (US);

Kirk Leister, Fayetteville, NY (US);

Linda Matlock, Parish, NY (US);

Stephen G. Zegarelli, North Syracuse, NY (US);

Christoph E. Joosten, Manlius, NY (US);

Jonathan D. Basch, DeWitt, NY (US);

Sivakesava Sakhamuri, Manlius, NY (US);

Steven S. Lee, Manlius, NY (US);

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 15/09 (2006.01); C12N 15/06 (2006.01); C12N 15/56 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention describes methods and processes for the production of proteins, particularly glycoproteins, by animal cell or mammalian cell culture, illustratively, but not limited to, fed-batch cell cultures. The methods comprise feeding the cells with D-galactose, preferably with feed medium containing D-galactose, preferably daily, to sustain a sialylation effective level of D-galactose in the culture for its duration, thus increasing sialylation of the produced proteins. The methods can also comprise at least two temperature shifts performed during the culturing period, in which the temperature is lower at the end of the culturing period than at the time of initial cell culture. The cell culture processes of the invention involving two or more temperature shifts sustain a high cell viability, and can allow for an extended protein production phase. The methods can also comprise the delayed addition of polyanionic compound at a time after innoculation. Supplementation of the cultures with D-galactose, preferably in a feed medium, to sustain galactose at sialylation effective levels in the cultures until the end of a culture run reverses a decline in sialylation that accompanies culture scale up, and is advantageous for large scale culturing processes.


Find Patent Forward Citations

Loading…